MDxHealth SA Statistics
Share Statistics
MDxHealth SA has 49.50M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 49.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 36.12M |
| Failed to Deliver (FTD) Shares | 153 |
| FTD / Avg. Volume | 0.1% |
Short Selling Information
The latest short interest is 14.24K, so 0.03% of the outstanding shares have been sold short.
| Short Interest | 14.24K |
| Short % of Shares Out | 0.03% |
| Short % of Float | 0.04% |
| Short Ratio (days to cover) | 0.15 |
Valuation Ratios
The PE ratio is -2.37 and the forward PE ratio is -3.35.
| PE Ratio | -2.37 |
| Forward PE | -3.35 |
| PS Ratio | 1.45 |
| Forward PS | 1.2 |
| PB Ratio | 14.16 |
| P/FCF Ratio | -3.85 |
| PEG Ratio | n/a |
Enterprise Valuation
MDxHealth SA has an Enterprise Value (EV) of 120.97M.
| EV / Earnings | -2.81 |
| EV / Sales | 1.72 |
| EV / EBITDA | -3.97 |
| EV / EBIT | -4.43 |
| EV / FCF | -4.56 |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 5.02.
| Current Ratio | 1.95 |
| Quick Ratio | 1.81 |
| Debt / Equity | 5.02 |
| Total Debt / Capitalization | 83.4 |
| Cash Flow / Debt | -0.59 |
| Interest Coverage | -4.9 |
Financial Efficiency
Return on equity (ROE) is -5.98% and return on capital (ROIC) is -56.38%.
| Return on Equity (ROE) | -5.98% |
| Return on Assets (ROA) | -0.33% |
| Return on Capital (ROIC) | -56.38% |
| Revenue Per Employee | 233.98K |
| Profits Per Employee | -143.67K |
| Employee Count | 300 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 9.45 |
Taxes
| Income Tax | 1K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -26.99% in the last 52 weeks. The beta is -393982.88, so MDxHealth SA's price volatility has been lower than the market average.
| Beta | -393982.88 |
| 52-Week Price Change | -26.99% |
| 50-Day Moving Average | 1.99 |
| 200-Day Moving Average | 2.54 |
| Relative Strength Index (RSI) | 70.88 |
| Average Volume (20 Days) | 145.93K |
Income Statement
In the last 12 months, MDxHealth SA had revenue of $70.19M and earned -$43.10M in profits. Earnings per share was $-1.66.
| Revenue | 70.19M |
| Gross Profit | 43.93M |
| Operating Income | -27.33M |
| Net Income | -43.10M |
| EBITDA | -30.47M |
| EBIT | -27.33M |
| Earnings Per Share (EPS) | -1.66 |
Balance Sheet
The company has $22.38M in cash and $41.27M in debt, giving a net cash position of -$18.89M.
| Cash & Cash Equivalents | 22.38M |
| Total Debt | 41.27M |
| Net Cash | -18.89M |
| Retained Earnings | -331.45M |
| Total Assets | 157.41M |
| Working Capital | 24.65M |
Cash Flow
In the last 12 months, operating cash flow was -$21.50M and capital expenditures -$5.02M, giving a free cash flow of -$26.52M.
| Operating Cash Flow | -21.50M |
| Capital Expenditures | -5.02M |
| Free Cash Flow | -26.52M |
| FCF Per Share | -1.02 |
Margins
Gross margin is 62.58%, with operating and profit margins of -38.93% and -61.4%.
| Gross Margin | 62.58% |
| Operating Margin | -38.93% |
| Pretax Margin | -61.4% |
| Profit Margin | -61.4% |
| EBITDA Margin | -43.41% |
| EBIT Margin | -38.93% |
| FCF Margin | -37.78% |
Dividends & Yields
MDXH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -69.75% |
| FCF Yield | -22.51% |
Analyst Forecast
The average price target for MDXH is $7, which is 194.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 194.1% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Nov 14, 2023. It was a backward split with a ratio of 1:10.
| Last Split Date | Nov 14, 2023 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -2.55 |
| Piotroski F-Score | 2 |